We injected CT26, 4T1 and B16F10 MMRd or MMRp cell lines in mice and used anti-TIM3/TIGIT/LAG3/CTLA4 alone or in combination with anti-PD-1, 14 days following tumor inoculation. The gene discussed is HAVCR2; the disease is neoplasm.